Welcure Drugs & Pharmaceuticals Secures Export Sourcing Orders Worth Rs. 856 Million

Welcure Drugs & Pharmaceuticals Ltd has executed two fresh export sourcing assignments with Giant Exim and Ravina International, worth approximately Rs. 856 Million. The orders will contribute fee-based revenue, with no inventory or logistics risk to the Company. Commission income will be recognised on dispatch of each lot and is expected to enhance margins in the current quarter. The Company is in advanced discussions with additional international buyers for similar export sourcing mandates and expects to conclude further orders worth Rs. 200 Million or more within the ongoing quarter. These transactions are in the ordinary course of business and do not constitute related-party transactions under SEBI LODR. The Company remains focused on expanding its fee-based export portfolio while maintaining its debt-free capital structure.